Top Corteva Executive Makes Major Move With Personal Stock Holdings

New insider activity at Corteva ( (CTVA) ) has taken place on February 24, 2026.

Corteva’s VP, Controller and Principal Accounting Officer, Brian Titus, has sold 8,311 shares of Corteva stock in a transaction valued at $636,170, according to recently reported filings.

Recent Updates on CTVA stock

Corteva shares saw activity as multiple analysts shifted to more cautious stances, largely because the stock has rallied close to their fair‑value estimates, making valuation less compelling. UBS also flagged execution and negative‑surprise risk around the planned split of the Seed and Crop Protection businesses later this year, which tempers the near‑term risk/reward.

JPMorgan likewise cited valuation in moving to a more neutral view, even while acknowledging Corteva’s solid earnings trajectory and 2026 EBITDA and EPS growth targets. The firm pointed to added uncertainty from the complex separation into distinct seed and crop chemical companies, as well as ongoing industry headwinds such as crop protection pricing pressure, tariffs, and mixed farmer economics, all of which could affect the pace at which the company can realize its strategic and cash‑flow ambitions.

Spark’s Take on CTVA Stock

According to Spark, TipRanks’ AI Analyst, CTVA is a Outperform.

The score is driven primarily by solid financial health (low leverage, improving margins, strong recent free cash flow) and a constructive earnings outlook with reiterated 2026 growth guidance and licensing/royalty tailwinds from the Bayer agreement. These positives are tempered by a rich valuation (high P/E, low yield) and technically overbought momentum, plus revenue inconsistency and pricing/tariff/FCF-normalization risks highlighted on the call.

To see Spark’s full report on CTVA stock, click here.

More about Corteva

YTD Price Performance: 14.90%

Average Trading Volume: 3,806,752

Technical Sentiment Signal: Buy

Current Market Cap: $51.51B